Fund Holdings — B Group, Inc.

Total Portfolio Value:
$115.09M
Total Bought:
$16.55M
Total Sold:
$64.73M
Net Transaction:
-$48.18M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Adma Biologics Inc2,287,5422,317,542+30,000$39.23M$45.98M39.95%+$6.75M
Insmed Incorporated(INSM)350,000262,500-87,500$24.16M$20.03M17.40%-$4.14M
Zai Lab LimitedADR(ZLAB)400,000400,0000$10.48M$14.46M12.56%+$3.98M
Akero Therapeutics Inc260,000242,500-17,500$7.23M$9.82M8.53%+$2.58M
Iovance Biotherapeutics, Inc.(IOVA)992,0001,500,000+508,000$7.34M$5.00M4.34%-$2.35M
Cellectis S.A.ADS(CLLS)3,081,5013,256,501+175,000$5.55M$4.04M3.51%-$1.51M
Aura Biosciences, Inc.(AURA)472,576472,5760$3.88M$2.77M2.41%-$1.12M
Sight Sciences, Inc.(SGHT)629,370833,600+204,230$2.29M$2.00M1.74%-$290.3K
Assembly Biosciences Inc50,651200,000+149,349$799.3K$1.91M1.66%+$1.11M
Taysha Gene Therapies, Inc.(TSHA)965,5561,255,556+290,000$1.67M$1.75M1.52%+$74.8K
Ultragenyx Pharmaceutical Inc.(RARE)7,59647,500+39,904$319.6K$1.72M1.49%+$1.40M
BioNTech SEADS(BNTX)3,50015,000+11,500$398.8K$1.37M1.19%+$967.1K
Spyre Therapeutics, Inc.(SYRE)50,00070,000+20,000$1.16M$1.13M0.98%-$34.5K
Apogee Therapeutics Inc15,00030,000+15,000$679.5K$1.12M0.97%+$441.3K
Praxis Precision Medicines, Inc.(PRAX)019,000+19,000$0$719.5K0.63%+$719.5K
89bio Inc095,623+95,623$0$695.2K0.60%+$695.2K
Oruka Therapeutics, Inc.(ORKA)20,00058,215+38,215$387.8K$597.3K0.52%+$209.5K
Corvus Pharmaceuticals, Inc.PUT(CRVS)100,0000-100,000$535.0K$0—-$535.0K
Invesco Qqq TrPUT
PUT
110,0000-110,000$56.24M$0—-$56.24M
Ultragenyx Pharmaceutical InCALL
CALL
29,5000-29,500$1.24M$0—-$1.24M
Page 1 of 1
B Group, Inc. — 13F Holdings — Q1 2025 | TickerTrail